Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheryl Green

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancerJamie A Cesaretti, Richard G Stock, Steven Lehrer, et al.
The Journal of Sexual Medicine|October 31, 2025
Motivators for sexual activity among women who are cancer survivors: a cross-sectional studyMelanie Besculides, Julia Brody-Barre, Lauren M Carney, et al.
Psycho-Oncology|June 11, 2025
Breast and Pelvic Cancer Survivors' Preferences for Psychosexual Interventions to Address Sexual Health Concerns: A Qualitative StudyLauren M Carney, Melanie Besculides, Ksenia Gorbenko, et al.
Frontiers in Oncology|July 18, 2022
The Cognitive Effects of Radiotherapy for Brain MetastasesEric J Lehrer, Brianna M Jones, Daniel R Dickstein, et al.
Global Qualitative Nursing Research|May 18, 2026
Informing Equity-Oriented Approaches to Postpartum Care Following Severe Maternal Morbidity Events: A Qualitative Descriptive Study ProtocolSusan M Jack, Daniel J Atkinson, Amanda Hicks, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Genetic predictors of adverse radiotherapy effects: the Gene-PARE projectAlice Y Ho, David P Atencio, Sheila Peters, et al.
Acta Oncologica (Stockholm, Sweden)|August 7, 2023
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomesVincent Vakaet, Pieter Deseyne, Renée Bultijnck, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancerJamie A Cesaretti, Richard G Stock, Steven Lehrer, et al.
The Journal of Sexual Medicine|October 31, 2025
Motivators for sexual activity among women who are cancer survivors: a cross-sectional studyMelanie Besculides, Julia Brody-Barre, Lauren M Carney, et al.
Psycho-Oncology|June 11, 2025
Breast and Pelvic Cancer Survivors' Preferences for Psychosexual Interventions to Address Sexual Health Concerns: A Qualitative StudyLauren M Carney, Melanie Besculides, Ksenia Gorbenko, et al.
Frontiers in Oncology|July 18, 2022
The Cognitive Effects of Radiotherapy for Brain MetastasesEric J Lehrer, Brianna M Jones, Daniel R Dickstein, et al.
Global Qualitative Nursing Research|May 18, 2026
Informing Equity-Oriented Approaches to Postpartum Care Following Severe Maternal Morbidity Events: A Qualitative Descriptive Study ProtocolSusan M Jack, Daniel J Atkinson, Amanda Hicks, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Genetic predictors of adverse radiotherapy effects: the Gene-PARE projectAlice Y Ho, David P Atencio, Sheila Peters, et al.
Acta Oncologica (Stockholm, Sweden)|August 7, 2023
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomesVincent Vakaet, Pieter Deseyne, Renée Bultijnck, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Pageof 9